Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice
- 15 April 2011
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 332 (6027), 358-361
- https://doi.org/10.1126/science.1192149
Abstract
Transforming growth factor–β (TGFβ) signaling drives aneurysm progression in multiple disorders, including Marfan syndrome (MFS), and therapies that inhibit this signaling cascade are in clinical trials. TGFβ can stimulate multiple intracellular signaling pathways, but it is unclear which of these pathways drives aortic disease and, when inhibited, which result in disease amelioration. Here we show that extracellular signal–regulated kinase (ERK) 1 and 2 and Smad2 are activated in a mouse model of MFS, and both are inhibited by therapies directed against TGFβ. Whereas selective inhibition of ERK1/2 activation ameliorated aortic growth, Smad4 deficiency exacerbated aortic disease and caused premature death in MFS mice. Smad4-deficient MFS mice uniquely showed activation of Jun N-terminal kinase–1 (JNK1), and a JNK antagonist ameliorated aortic growth in MFS mice that lacked or retained full Smad4 expression. Thus, noncanonical (Smad-independent) TGFβ signaling is a prominent driver of aortic disease in MFS mice, and inhibition of the ERK1/2 or JNK1 pathways is a potential therapeutic strategy for the disease.Keywords
Funding Information
- National Institutes of Health
- National Human Genome Research Institute
This publication has 30 references indexed in Scilit:
- Fibulin-4 Deficiency Results in Ascending Aortic AneurysmsCirculation Research, 2010
- TGF-β in the pathogenesis and prevention of disease: a matter of aneurysmic proportionsJCI Insight, 2010
- The Extracellular Matrix: Not Just Pretty FibrilsScience, 2009
- Syndromic and non‐syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathwayThe Journal of Pathology, 2009
- TRAF6 Mediates Smad-Independent Activation of JNK and p38 by TGF-βMolecular Cell, 2008
- TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcAThe EMBO Journal, 2007
- Mediating ERK1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndromeJCI Insight, 2007
- Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic statesNature Medicine, 2007
- Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan SyndromeScience, 2006
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003